For months, the medical world has been waiting to see a paper co-authored by U.S. Food and Drug Administration safety expert David Graham .
The new administration recently appointed a statistical sampling expert to be the next census director.
Such talk infuriates Peter Orszag, the head of the White House's Office of Management and Budget and the administration's most important health expert.
On Tuesday, I wrote about an analysis of how often the Food and Drug Administration follows the advice of its expert advisory panels on whether or not to approve a new drug.
Indeed, the results are positive enough that one leading pain expert in the US argues the Food and Drug Administration (FDA) should only license abuse resistant painkillers.
The Food and Drug Administration has released the briefing documents for the expert meeting in which it will ask a panel of doctors whether or not the GlaxoSmithKline diabetes drug Avandia should remain on the market, and, if so, what warnings patients should get before they take it.
In so doing, the former U.S. Ambassador to Yugoslavia, ertswhile American-Yugoslav entrepreneur (involved in banking arrangements and "Yugo" automobile franchises) and current resident "expert" on Yugoslavia in the State Department exemplified the failure of Bush Administration policy toward this crisis: He ignored the very real responsibility Washington and other Western capitals share for the present crisis.
Craig Van Grasstek, an expert on American trade politics, thinks Republicans in Congress may try to exploit the administration's discomfort and the Democrats' divisions by tying a big trade bill to the China vote.
Max Boot, a senior fellow at the Council on Foreign Relations and an expert on guerrilla warfare, in an otherwise favorable Wall Street Journal piece, takes the Administration to task for not doing more to stop Syria from being a sanctuary for Iraqi insurgents.
应用推荐